Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01611714 · ClinicalTrials.gov registry record · NA

Equity in Diagnostic Imaging Trial

A NA study of Headache, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
181
Enrollment target
1
Study location

NCT01611714 is a NA study of Headache that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 181 participants, above the 150-participant average among 35 other Headache trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01611714, a NA study of Headache, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
181 participants
Enrollment target
1
Study location

Study Summary

This study will 1) Develop two interventions: a) an audit-feedback email intervention that provides clinicians with data on CT scan ordering practices by patient race; and b) a clinical decision support (CDS) message in the electronic medical record headache template; and 2) Compare the effectiveness of these 2 interventions in eliminating a previously observed Black-White disparity in CT scanning rates to rule out subarachnoid hemorrhage (SAH).

Conditions Studied

Interventions

  • OTHER Clinical Decision Support
  • OTHER Audit-feedback

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 181 participants
Start Date 2010-07
Est. Completion 2015-12
Phase NA

What the Registry Record Tells You About NCT01611714

The ClinicalTrials.gov registry entry for NCT01611714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 150-participant average among 35 other Headache trials with a reported enrollment target (21% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Headache appearing as the primary indexed condition, and to 2 interventions - of which Clinical Decision Support is the first listed.

NCT01611714 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01611714 about?

NCT01611714 is a clinical study titled "Equity in Diagnostic Imaging Trial". This study will 1) Develop two interventions: a) an audit-feedback email intervention that provides clinicians with data on CT scan ordering practices by patient race; and b) a clinical decision support (CDS) message in the electronic medical record headache template; and 2) Compare the effectivenes...

What is the current status of trial NCT01611714?

This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2010-07. Estimated completion is 2015-12.

What conditions does trial NCT01611714 study?

This clinical trial studies the following conditions: Headache.

What interventions are being tested in trial NCT01611714?

The interventions under investigation include: Clinical Decision Support (OTHER), Audit-feedback (OTHER).

Who is sponsoring clinical trial NCT01611714?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01611714 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Headache

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.